In the news

A Multi-state outbreak of Salmonella Mbandaka is being investigated by the FDA, CDC, along with state and local officials. Kellogg’s Honey Smacks sweetened puffed wheat cereal seems to be the source of this outbreak. The CDC reports that 73 people in 31 states have become ill, with 24 hospitalizations and no deaths. The Kellogg Company voluntarily recalled Kellogg’s Honey Smacks cereal. The recalled products were distributed across the United States including Guam and Saipan and in Aruba/Curaçao/Saint Maarten (Netherlands Antilles), the Bahamas, Barbados, Tortola (British Virgin Islands), Costa Rica, Guatemala, Haiti, Mexico, Panama, and Tahiti (French Polynesia). The FDA is advising consumers not to eat any Honey Smack cereal. Kellogg launched an investigation with the third-party manufacturer who produces Honey Smacks immediately after being contacted by the Food & Drug Administration (FDA) and Centers for Disease Control (CDC) regarding reported illnesses. @ https://www.fda.gov/Food/RecallsOutbreaksEmergencies/Outbreaks/ucm610827.htm?utm_campaign=Outbreak_Salmonella_Mbandaka_Honey_Smacks_06142018&utm_medium=email&utm_source=Eloqua&elqTrackId=e77671e668e844959c08d8b13ea89918&elq=c9448dc008604559a36ec66570293a2d&elqaid=3926&elqat=1&elqCampaignId=3052

{“post_id”:3738,”post_type”:”post”,”shortcode”:”peepso_postnotify”,”permalink”:”https:\/\/ask-bioexpert.com\/all\/smart-sensors-the-internet-of-things-blockchain-and-the-cloud-the-perfect-combination-for-food-safety-introduction\/”}

According to CDC, each year in the U.S. at least 2 million people are infected with bacteria resistant to antibiotics and 23,000 people die each year as a result of these infections. Despite the growing occurrence of resistant strains, there has been an overall decline in antibiotic drug research. This is especially true for the development of new antibiotics that work through novel mechanisms that can evade existing patterns of resistance. Developing new drugs is a costly venture. New drugs are used sparsely to avoid overexposure. Therefore, it means that a novel antibiotic may have a very limited market, making them economically not profitable. The FDA and other federal agencies are taking new steps to address each of these challenges, including new efforts to address the need for better economic incentives. Bacteria will continue to evolve. Many of the existing antibiotics are old. FDA will need to continuously encourage the development of new therapeutic options to keep pace with these challenges. @ https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm610503.htm?utm_campaign=06122018_Statement_FDA%E2%80%99s%20efforts%20to%20foster%20new%20tools%20to%20fight%20antimicrobial%20resistance&utm_medium=email&utm_source=Eloqua

In the final report, there have been 1049 confirmed cases from 01 January 2017 to 05 June 2018. After the implicated Polony was recalled the number of cases reported had consistently declined. Measures are being taken to avoid such outbreaks in the future, this includes training people, conducting risk assessment for all factories, and creating a dedicated website. Risk assessments have been received from 310 food processing facilities from 8 provinces, of which 79 are from meat processing facilities. A plan is being developed to terminate the current outbreak and to strengthen systems to facilitate prevention and early detection of outbreaks. @ https://www.foodpoisonjournal.com/files/2018/06/Listeriosis-outbreak-situation-report-_11June2018_final.pdf